Cell-based Flu Vaccine Market
Cell-based Flu Vaccine Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Cell-based Flu Vaccine Market Size and Growth
The cell-based flu vaccine market is experiencing robust growth, driven by increasing demand for effective immunization and advancements in vaccine production. Market size is projected to reach approximately $2.5 billion by 2026, reflecting a CAGR of around 10% due to rising health awareness and pandemic preparedness initiatives globally. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ GlaxoSmithKline
◍ Sanofi
◍ Pfizer
◍ MedImmune, LLC
◍ Intravacc
◍ CSL Limited
◍ E. Merck KG
◍ Novartis
◍ Danaher Corporation
◍ SINOVAC
The cell-based flu vaccine market features companies like GlaxoSmithKline, Sanofi, and Pfizer, advancing vaccine technology and production efficiency. They enhance market growth through innovative research and strategic collaborations. Notable sales figures include:
- GlaxoSmithKline: $43 billion
- Sanofi: $39 billion
- Pfizer: $81 billion.
Request Sample Report
Market Segmentation
By Application
Aldults
Children
Request Sample Report
By Product
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market Growth
Request Sample Report
$ X Billion USD
